BELKIN Vision Overview
- Year Founded
-
2013
- Status
-
Acquired/Merged
- Employees
-
22
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$92M
BELKIN Vision General Information
Description
Developer of a laser device designed to assist healthcare professionals in treating glaucoma. The company offers non-invasive, non-contact, instantaneous, painless and automated devices offering laser therapy and is aimed at promoting accessibility to first-line drop-less glaucoma care by allowing any ophthalmologist to treat patients, enabling the medical community and patients to improve treatment outcomes and to get better care.
Contact Information
Website
www.belkin-vision.com(Operating Subsidiary)
Corporate Office
- 13 Gan Raveh Street
- Yavne 8122214
- Israel
Corporate Office
- 13 Gan Raveh Street
- Yavne 8122214
- Israel
BELKIN Vision Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 16. Merger/Acquisition | 01-Jul-2024 | $92M | Completed | Generating Revenue | ||
| 15. Later Stage VC | 01-Feb-2024 | Completed | Generating Revenue | |||
| 14. Grant | Completed | Generating Revenue | ||||
| 13. Grant | 14-Sep-2022 | Completed | Generating Revenue | |||
| 12. Later Stage VC | 20-Dec-2021 | Completed | Generating Revenue | |||
| 11. Grant | 06-Oct-2021 | Completed | Generating Revenue | |||
| 10. Later Stage VC (Series B) | 20-Jul-2020 | Completed | Generating Revenue | |||
| 9. Early Stage VC | Completed | Clinical Trials - General | ||||
| 8. Early Stage VC (Series A) | 04-Jun-2017 | $2.5M | $3.6M | Completed | Clinical Trials - General | |
| 7. Grant | 04-Jun-2017 | $2.78M | $1.1M | Completed | Clinical Trials - General |
BELKIN Vision Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| B1 Preferred | ||||||||
| B Preferred | ||||||||
| A1 Preferred | 221,551 | $2.48 | $2.48 | 1x | $2.48 | 5.44% | ||
| A Preferred | 755,287 | $3.31 | $3.31 | 1x | $3.31 | 18.55% |
BELKIN Vision Comparisons
Industry
Financing
Details
BELKIN Vision Competitors (11)
One of BELKIN Vision’s 11 competitors is Oscor, a Corporate Backed or Acquired company based in Palm Harbor, FL.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Oscor | Corporate Backed or Acquired | Palm Harbor, FL | ||||
| Kardium | Private Equity-Backed | Burnaby, Canada | ||||
| Deka Laser | Corporation | Florence, Italy | ||||
| Lumenis | Private Equity-Backed | Yokneam, Israel | ||||
| Cynosure (Other Devices and Supplies) | Private Equity-Backed | Westford, MA |
BELKIN Vision Patents
BELKIN Vision Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4537738-A2 | Gonioscopic laser surgery | Pending | 09-Oct-2023 | ||
| EP-4537738-A3 | Gonioscopic laser surgery | Pending | 09-Oct-2023 | ||
| JP-2025065578-A | Gonioscopic laser surgery | Pending | 09-Oct-2023 | ||
| EP-4633565-A1 | Automated transscleral cyclophotocoagulation | Pending | 15-Dec-2022 | ||
| EP-4633565-A4 | Automated transscleral cyclophotocoagulation | Pending | 15-Dec-2022 | G02C7/047 |
BELKIN Vision Signals
BELKIN Vision Former Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| ARC Innovation Center | Accelerator/Incubator | |||
| BioLight Life Sciences | Venture Capital | Minority | ||
| C-MER Medical Holdings | Corporation | Minority | ||
| China Resources Capital Management | Corporate Venture Capital | Minority | ||
| European Innovation Council | Accelerator/Incubator | Minority |
BELKIN Vision FAQs
-
When was BELKIN Vision founded?
BELKIN Vision was founded in 2013.
-
Where is BELKIN Vision headquartered?
BELKIN Vision is headquartered in Yavne, Israel.
-
What is the size of BELKIN Vision?
BELKIN Vision has 22 total employees.
-
What industry is BELKIN Vision in?
BELKIN Vision’s primary industry is Diagnostic Equipment.
-
Is BELKIN Vision a private or public company?
BELKIN Vision is a Private company.
-
What is the current valuation of BELKIN Vision?
The current valuation of BELKIN Vision is .
-
What is BELKIN Vision’s current revenue?
The current revenue for BELKIN Vision is .
-
How much funding has BELKIN Vision raised over time?
BELKIN Vision has raised $28.7M.
-
Who are BELKIN Vision’s investors?
ARC Innovation Center, BioLight Life Sciences, C-MER Medical Holdings, China Resources Capital Management, and European Innovation Council are 5 of 14 investors who have invested in BELKIN Vision.
-
Who are BELKIN Vision’s competitors?
Oscor, Kardium, Deka Laser, Lumenis, and Cynosure (Other Devices and Supplies) are some of the 11 competitors of BELKIN Vision.
-
When was BELKIN Vision acquired?
BELKIN Vision was acquired on 01-Jul-2024.
-
Who acquired BELKIN Vision?
BELKIN Vision was acquired by Alcon.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process